Background: Dexpanthenol containing formula (BEPANTHEN？), formulated as a water in oil preparation, is currently widely marketed as a diaper care product aiming to protect baby’s buttocks and repair diaper dermatitis. Dexpanthenol is a well-known moisturizer with barrier-improving properties and the oily phase of the water in oil preparation forms a lipophilic film on the skin surface that isolates the skin from irritants (feces and urine). Prolonged contact with irritants triggers a local inflammation cascade responsible for the cutaneous erythema. To further investigate the protective properties of skin barrier preparations, we took advantage of an ex vivo model of healthy human skin discs especially designed to evaluate protective and/or repairing effects of topical preparations recommended for baby’s buttocks through the measurement of interleukin-1 alpha release (a cytokine considered as the Primum movens of the skin inflammatory reaction), following the application of different irritants. Methods: Healthy human skin discs have been incubated in the absence (control) or in the presence of two irritants, i.e. a “urine like + urease” preparation and sodium dodecyl sulfate, and in the presence of three ointments, one containing dexpanthenol, but not the other two. At the end of the incubation period, interleukin-1 alpha (IL-1α) was quantified in the explants culture media. Results: “Urine like + urease” preparation (ULU) and sodium dodecyl sulfate (SDS) both increased IL-1α production of skin explants by 181.1% (p < 0.001) and 88.3% (p < 0.001), respectively. The dexpanthenol containing formula significantly inhibited the ULU- and the SDS-induced IL-1α release by 67.42% (p < 0.001) and 46.55% (p < 0.001), respectively. Under the same experimental conditions, one of the formulas without dexpanthenol significantly inhibited the ULU-induced IL-1α release by 45.94% (p < 0.01) but not the SDS-induced one, and the other tested formulation displayed no significant effect on the IL-1α production regardless of the irritant applied. Moreover, the effect of the dexpanthenol containing formula on the ULU-induced IL-1α release was significantly higher than the effect of the other formula; a difference of 19.6 % (p < 0.05) was observed. Conclusion: Dexpanthenol containing formula (BEPANTHEN？) provides good protection of baby’s buttocks against irritants. Its protective
References
[1]
Berg, R., Buckingham, K. and Stewart, R. (1986) Etiologic Factors in Diaper Dermatitis: The Role of Urine. Pediatric Dermatology, 3, 102-106. https://doi.org/10.1111/j.1525-1470.1986.tb00498.x
[2]
Atherton, D., Proksch, E., Schauber, J. and Stalder, J. (2015) Irritant Diaper Dermatitis: Best Practice Management. SelfCare, 6, 1-11.
[3]
Proksch, E., de Bony, R., Trapp, S. and Boudon, S. (2017) Topical Use of Dexpanthenol: A 70th Anniversary Article. Journal of Dermatological Treatment, 28, 766-773. https://doi.org/10.1080/09546634.2017.1325310
[4]
Abiko, Y., Tomikawa, M. and Shimizu, M. (1969) Enzymatic Conversion of Pantothenylalcohol to Pantothenic Acid. The Journal of Vitaminology, 15, 59-69. https://doi.org/10.5925/jnsv1954.15.59
[5]
Proksch, E. and Jensen, J. (2006) Handbook of Cosmetic Science and Technology. 2nd Edition, Taylor & Francis Group, New York, London, 399-406. https://doi.org/10.1201/b14400-33
[6]
Proksch, E., Holleran, W., Menon, G., Elias, P. and Feingold, K. (1993) Barrier Function Regulates Epidermal Lipid and DNA Synthesis. British Journal of Dermatology, 128, 473-482. https://doi.org/10.1111/j.1365-2133.1993.tb00222.x
[7]
Slyshenkov, V., Rakowska, M., Moiseenok, A. and Wojtczak, L. (1995) Pantothenic Acid and Its Derivatives Protect Ehrlich Ascites Tumor Cells against Lipid Peroxidation. Free Radical Biology & Medicine, 19, 767-772. https://doi.org/10.1016/0891-5849(95)00084-B
[8]
Proksch, E. and Nissen, H. (2002) Dexpanthenol Enhances Skin Barrier Repair and Reduces Inflammation after Sodium Lauryl Sulfate-Induced Irritation. Journal of Dermatological Treatment, 13, 173-178. https://doi.org/10.1080/09546630212345674
[9]
Stozkowska, W. and Piekos, R. (2004) Investigation of Some Topical Formulations Containing Dexpanthenol. Acta Poloniae Pharmaceutica, 61, 433-437.
[10]
Putet, G., Guy, B., Pages, S., Gibaud, C., Andres, P., Sirvent, A., Puffay, P., de Bony, R. and Girard, F. (2000) Effect of Bepanthen Ointment in the Prevention of Diaper Rash on Premature and Full-Term Babies: Open Pilot Study. Realites Pediatriques, 52, 21-28.
[11]
Putet, G., Guy, B., Andres, P., Sirvent, A., de Bony, R. and Girard, F. (2001) Effect of Bepanthen Ointment on the Prevention and Treatment of Diaper Rash on Premature and Full-Term Babies. Realites Pediatriques, 63, 33-38.
[12]
Degouy, A., Gomez-Berrada, M. and Ferret, P. (2014) Baby Care Product Development: Artificial Urine in Vitro Assay Is Useful for Cosmetic Product Assessment. Toxicology in Vitro, 28, 3-7. https://doi.org/10.1016/j.tiv.2013.06.022
[13]
Norris, D. (1990) Cytokine Modulation of Adhesion Molecules in the Regulation of Immunologic Cytotoxicity of Epidermal Targets. Journal of Investigative Dermatology, 95, 111S-120S. https://doi.org/10.1111/1523-1747.ep12874977
[14]
Perkins, M., Osterhues, M., Farage, M. and Robinson, M. (2001) A Noninvasive Method to Assess Skin Irritation and Compromised Skin Conditions Using Simple Tape Adsorption of Molecular Markers of Inflammation. Skin Research and Technology, 7, 227-237. https://doi.org/10.1034/j.1600-0846.2001.70405.x
[15]
Garcia Bartels, N., Massoudy, L., Scheufele, R., Dietz, E., Proquitté, H., Wauer, R., Bertin, C., Serrano, J. and Blume-Peytavi, U. (2012) A Prospective, Randomized Pilot Study on Skin Barrier Function and Epidermal IL-1α in Newborns. Pediatric Dermatology, 29, 270-276. https://doi.org/10.1111/j.1525-1470.2011.01590.x
[16]
Shmaefsky, B. (1995) Artificial Urine for Laboratory Testing-Revisited. The American Biology Teacher, 57, 428-430. https://doi.org/10.2307/4450032
[17]
Nitto, T. and Onodera, K. (2013) Linkage between Coenzyme A Metabolism and Inflammation: Roles of Pantotheinase. Journal of Pharmacological Sciences, 123, 1-8. https://doi.org/10.1254/jphs.13R01CP
[18]
Serhan, C., Chiang, N. and Van Dyke, T. (2008) Resolving Inflammation: Dual Anti-Inflammatory and Pro-Resolution Lipid Mediators. Nature Reviews Immunology, 8, 349-361. https://doi.org/10.1038/nri2294
[19]
Blume-Peytavi, U., Hauser, M., Stamatas, G., Pathirina, D. and Garcia Bartels, N. (2012) Skin Care Practices for Newborns and Infants: Review of the Clinical Evidence for Best Practices. Pediatric Dermatology, 29, 1-14. https://doi.org/10.1111/j.1525-1470.2011.01594.x
